Cargando…

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases

The ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the development of cardiovascular disease (CVD) has sparked interests in understanding the common mediators between the two biologically distinct entities. This comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chew, Nicholas W.S., Chong, Bryan, Ng, Cheng Han, Kong, Gwyneth, Chin, Yip Han, Xiao, Wang, Lee, Mick, Dan, Yock Young, Muthiah, Mark D., Foo, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399730/ https://www.ncbi.nlm.nih.gov/pubmed/36035124 http://dx.doi.org/10.3389/fgene.2022.971484

Ejemplares similares

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

What's in a disease like non‐alcoholic fatty liver disease—East versus West?
por: Dan, Yock Young
Publicado: (2022)

The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Quek, Jingxuan, et al.
Publicado: (2021)

Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
por: Anand, Vickram Vijay, et al.
Publicado: (2023)

Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
por: Chong, Bryan, et al.
Publicado: (2023)

Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
por: Ng, Chun‐Yi, et al.
Publicado: (2022)

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
por: Ng, Cheng Han, et al.
Publicado: (2022)

The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer
por: Qiu, Ting, et al.
Publicado: (2022)

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
por: Yu, Xiaoxiao, et al.
Publicado: (2023)

Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease
por: Ye, Hua, et al.
Publicado: (2023)

Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
por: Luo, Lei, et al.
Publicado: (2018)

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
por: Yang, Fan, et al.
Publicado: (2023)

The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
por: Chin, Yip Han, et al.
Publicado: (2022)

Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
por: Lim, Wen Hui, et al.
Publicado: (2022)

Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2022)

Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease
por: Wu, Na, et al.
Publicado: (2022)

Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study
por: Wang, Xiaokun, et al.
Publicado: (2020)

Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease
por: Sabotta, Caroline M., et al.
Publicado: (2022)

Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis
por: Yeong, Trevor, et al.
Publicado: (2022)

Identification of biomarkers in nonalcoholic fatty liver disease: A machine learning method and experimental study
por: Han, Na, et al.
Publicado: (2022)

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
por: Tan, Darren Jun Hao, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
por: Tang, Ansel Shao Pin, et al.
Publicado: (2022)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Epigenetic Biomarkers in Cardiovascular Diseases
por: Soler-Botija, Carolina, et al.
Publicado: (2019)

Treatment of Fatty Liver Disease: The Present and the Future
por: Ramanan, Sruthi Priyavadhana, et al.
Publicado: (2021)

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population
por: Wang, Xiaoliang, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis
por: Han, A. L.
Publicado: (2021)

Effect of COVID-19 Pandemic on Influenza Vaccination Intention: A Meta-Analysis and Systematic Review
por: Kong, Gwyneth, et al.
Publicado: (2022)

The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease
por: Li, FangYuan, et al.
Publicado: (2021)

Editorial: RNA Biology in Cardiovascular Disease
por: van den Hoogenhof, Maarten M. G., et al.
Publicado: (2021)

Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases
por: Xu, Jinyu, et al.
Publicado: (2022)

Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population
por: Hao, Xiaoyan, et al.
Publicado: (2021)

Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients
por: Kong, Gwyneth, et al.
Publicado: (2022)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

Multi-Omics Analysis of Fatty Alcohol Production in Engineered Yeasts Saccharomyces cerevisiae and Yarrowia lipolytica
por: Dahlin, Jonathan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eb0hlri8mojhh2q5sj9pgo918h